Full Text View
Tabular View
No Study Results Posted
Related Studies
Electrogastrography (EGC) in Premature Infants With Feeding Intolerance
This study has been completed.

First Received on January 16, 2001.   Last Updated on June 23, 2005   History of Changes
Sponsor: National Center for Research Resources (NCRR)
Collaborator: Children's Hospital of Philadelphia
Information provided by: National Center for Research Resources (NCRR)
ClinicalTrials.gov Identifier: NCT00008736
  Purpose

Serial EGC measurements in premature infants attempting to correlate EGC measurements with signs of feeding intolerance and response to metoclopramide therapy.


Condition Intervention Phase
Infant, Newborn, Diseases
Drug: metoclopramide
Phase II

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Primary Purpose: Treatment
Official Title: Electrogastrography (EGC) in Premature Infants With Feeding Intolerance: The Effect of Metoclopramide

Resource links provided by NLM:


Further study details as provided by National Center for Research Resources (NCRR):

  Eligibility

Ages Eligible for Study:   up to 1 Month
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion:

Premature infants. Absence of 1) infection, 2) congenital anomalies, 3) growth retardation

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00008736

Locations
United States, Pennsylvania
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States, 19104
Sponsors and Collaborators
Children's Hospital of Philadelphia
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00008736     History of Changes
Other Study ID Numbers: NCRR-M01RR00240-1724
Study First Received: January 16, 2001
Last Updated: June 23, 2005
Health Authority: United States: Federal Government

Keywords provided by National Center for Research Resources (NCRR):
Feeding intolerance
Infant, premature

Additional relevant MeSH terms:
Infant, Newborn, Diseases
Metoclopramide
Antiemetics
Autonomic Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Pharmacologic Actions
Central Nervous System Agents
Therapeutic Uses
Gastrointestinal Agents
Dopamine Antagonists
Dopamine Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action

ClinicalTrials.gov processed this record on February 09, 2012